Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (81-90 of 389) with videos related to

Pageof 39
Sort By:
Lancet (London, England)|November 2, 2010
Drug harms in the UK: a multicriteria decision analysisDavid J Nutt, Leslie A King, Lawrence D Phillips, et al.
The Australian and New Zealand Journal of Psychiatry|July 6, 2005
Acute tryptophan depletion. Part I: rationale and methodologySean D Hood, Caroline J Bell, David J Nutt
Convulsive Therapy|January 1, 1988
Electroconvulsive Shock Does Not Increase Plasma Insulin in RatsArun B. Thiagarajan, Christoph H. Gleiter, David J. Nutt
Neuropharmacology|December 29, 2017
Psychiatry & the psychedelic drugs. Past, present & futureJames J H Rucker, Jonathan Iliff, David J Nutt
Nature Reviews. Neuroscience|October 24, 2013
New victims of current drug lawsDavid J Nutt, Leslie A King, David E Nichols
Journal of Clinical Psychopharmacology|January 25, 2003
Psychotropic drugs, cardiac arrhythmia, and sudden deathHarry J Witchel, Jules C Hancox, David J Nutt
International Review of Neurobiology|June 20, 2025
ForewordAnne Katrin Schlag, David J Nutt, Michael T Lynskey
JAMA Psychiatry|March 14, 2019
Why Less Is Always More in the Treatment of Alcohol Use DisordersDavid J Nutt, Antoni Gual, Peter Anderson, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2013
Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case seriesBedriye Öncü, Okan Er, Burçin Çolak, et al.
Convulsive Therapy|January 1, 1991
Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?Helen C. Jackson, Paul J. Weinberger, David J. Nutt
Pageof 39

Showing results (81-90 of 389) with videos related to

Sort By:
Pageof 39
Lancet (London, England)|November 2, 2010
Drug harms in the UK: a multicriteria decision analysisDavid J Nutt, Leslie A King, Lawrence D Phillips, et al.
The Australian and New Zealand Journal of Psychiatry|July 6, 2005
Acute tryptophan depletion. Part I: rationale and methodologySean D Hood, Caroline J Bell, David J Nutt
Convulsive Therapy|January 1, 1988
Electroconvulsive Shock Does Not Increase Plasma Insulin in RatsArun B. Thiagarajan, Christoph H. Gleiter, David J. Nutt
Neuropharmacology|December 29, 2017
Psychiatry & the psychedelic drugs. Past, present & futureJames J H Rucker, Jonathan Iliff, David J Nutt
Nature Reviews. Neuroscience|October 24, 2013
New victims of current drug lawsDavid J Nutt, Leslie A King, David E Nichols
Journal of Clinical Psychopharmacology|January 25, 2003
Psychotropic drugs, cardiac arrhythmia, and sudden deathHarry J Witchel, Jules C Hancox, David J Nutt
International Review of Neurobiology|June 20, 2025
ForewordAnne Katrin Schlag, David J Nutt, Michael T Lynskey
JAMA Psychiatry|March 14, 2019
Why Less Is Always More in the Treatment of Alcohol Use DisordersDavid J Nutt, Antoni Gual, Peter Anderson, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2013
Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case seriesBedriye Öncü, Okan Er, Burçin Çolak, et al.
Convulsive Therapy|January 1, 1991
Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?Helen C. Jackson, Paul J. Weinberger, David J. Nutt
Pageof 39